Decision Diagnostics Corp (DECN)

[Alydyr]

DECN Preferred Series D - IMPORTANT

If issued and converted, this would likely tank the DECN share price below .03/share almost overnight. DECN management issued amendments in Dec 2016 & Jan 2017 to increase the D preferred authorized.

The recently amended Series D preferred series was increased to 1,250 authorized. Not a big deal, unless you realize that each DECN preferred D share can be converted in 120,000 common shares. That's right, one D preferred can be converted into 120,000 common shares of DECN.

So, if all of the D is issued an converted, that would FLOOD the street with 150 MILLION common shares.

Now, some will argue that none has been "issued". So if DECN's intent was not to issue, then why did DECN file two amendments (Dec 2016 & again in Jan 2017) to increase the authorized?

Detail below from the OTC Markets filing released 3/31/2017....

Series “D” convertible preferred stock

We have designated 1,250 shares of our $0.001 preferred stock as 2012 Series “D”. As of this date, we have not issued
any shares of this issue of Preferred stock. Holders of series “D” convertible stock shall not have the right to vote on
matters that come before the shareholders. 2012 Series “D” convertible preferred stock may be converted three years (36
months) after distribution. The number of shares into which one share of 2012 Series “D” Preferred Stock shall be convertible into common stock shares is 1 for 120,000 shares of $0.001 par value common stock. In 4Q 2016 and 1Q 2017 the company amended the Designations of its 2012 Series “D” convertible stock in anticipation of a large investment by a private non-fund related party. Should this investment occur, the majority of or all of the 1,250 shares would be subscribed to. 2012 Series “D” convertible stock shall rank junior to all other classes of Preferred stock in the event of liquidation. Holders of 2012 Series “D” convertible stock shall not be entitled to a mandatory monthly dividend. Holders
of 2012 Series “D” shares may not convert these shares into common stock until the expiration of a 36 month holding
period, unless the holder has received an extraordinary allowance to convert shares earlier by the company’s Board of
Directors.

https://www.otcmarkets.com/financialReportViewer?symbol=DECN&id=168556